Suppr超能文献

头颈部皮肤鳞状细胞癌神经周围侵犯中αB-晶状体蛋白染色减少。

Reduced alphaB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Medical College of Georgia, Augusta, GA, USA.

出版信息

Otolaryngol Head Neck Surg. 2010 Mar;142(3 Suppl 1):S15-9. doi: 10.1016/j.otohns.2009.12.001.

Abstract

OBJECTIVE

Perineural invasion (PNI) in cutaneous squamous cell carcinoma of the head and neck (CSCCHN) carries poor prognosis. Tumor markers associated with neurotropism in CSCCHN have not been identified. Our objective was to study the expression of alphaB-crystallin in CSCCHN with neurotropism.

STUDY DESIGN

Cross-sectional review of pathologic specimens.

SETTING

Tertiary care center.

SUBJECTS AND METHODS

Tissue from patients with CSCCHN with clinical PNI who underwent surgery between 1998 and 2005 was immunostained for alphaB-crystallin. In addition, non-PNI CSCCHN and normal nerve sections were also stained. Staining intensity was calculated by the histologic, or H, score (product of the intensity and proportion of tumor cells stained). The H-score ranged from 0.0 to 3.0, with 0 indicating negative staining in all cells and 3.0 indicating strong staining in 100 percent of cells.

RESULTS

Tissue was available in 15 clinical PNI CSCCHN patients. The analysis was also carried out in 14 non-PNI patients matched by stage and four normal greater auricular nerve (GAN) sections. The mean H-score was 0.56 for CSCCHN with PNI, 1.06 for non-PNI CSCCHN, and 3.0 for normal nerves. The difference in H-score between PNI and non-PNI CSCCHN was statistically significant (P = 0.04).

CONCLUSION

CSCCHN with clinical PNI has decreased staining for alphaB-crystallin. This finding further demonstrates the differences between clinical PNI and non-PNI CSCCHN tumors. Additional studies are required to identify cell surface markers expressed by CSCCHN that confer neurotropism capabilities.

摘要

目的

头颈部皮肤鳞状细胞癌(CSCCHN)中的神经周围侵犯(PNI)预后不良。与 CSCCHN 神经趋向性相关的肿瘤标志物尚未确定。我们的目的是研究具有神经趋向性的 CSCCHN 中αB-晶状体蛋白的表达。

研究设计

病理标本的横断面回顾。

设置

三级护理中心。

受试者和方法

对 1998 年至 2005 年间接受手术治疗的具有临床 PNI 的 CSCCHN 患者的组织进行αB-晶状体蛋白免疫染色。此外,还对非 PNI CSCCHN 和正常神经切片进行了染色。染色强度通过组织学或 H 评分(染色细胞的强度和比例的乘积)计算。H 评分范围从 0.0 到 3.0,0 表示所有细胞均为阴性染色,3.0 表示 100%的细胞均为强染色。

结果

15 例临床 PNI CSCCHN 患者的组织可用。还对 14 例按分期匹配的非 PNI 患者和 4 例正常的耳大神经(GAN)切片进行了分析。PNI CSCCHN 的平均 H 评分为 0.56,非 PNI CSCCHN 的 H 评分为 1.06,正常神经的 H 评分为 3.0。PNI 和非 PNI CSCCHN 之间的 H 评分差异具有统计学意义(P = 0.04)。

结论

具有临床 PNI 的 CSCCHN 中αB-晶状体蛋白的染色减少。这一发现进一步证明了具有临床 PNI 和非 PNI CSCCHN 肿瘤之间的差异。需要进一步研究以确定赋予 CSCCHN 神经趋向性能力的细胞表面标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验